Healthcare & Life Sciences
CellCentric
United Kingdomcellcentric.com
CellCentric is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series C+, 2 tracked investors.
activeseries-c-plus
series-c-plus
Stage
2
Investors
About CellCentric
CellCentric is a company headquartered in the United Kingdom. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
CellCentric is a clinical-stage biotechnology company focused on developing inobrodib, a first-in-class oral p300/CBP inhibitor for treating specific cancers such as multiple myeloma, prostate cancer, and other hematological malignancies.
Explore CellCentric's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.